Skip to main content

BioAtla, Inc.

BCAB
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001826892

No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in BioAtla, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
80
−4 vs. Q1 2024
Shares held
22.1M
−3.22M (−12.7%) vs. Q1 2024
Total value
$30.4M
−$56.8M (−65.1%) vs. Q1 2024
New holders
26
17 more added
Sold out
30
29 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 80 institutions
Q1 2021: 62 institutionsQ2 2021: 76 institutionsQ3 2021: 87 institutionsQ4 2021: 81 institutionsQ1 2022: 97 institutionsQ2 2022: 80 institutionsQ3 2022: 73 institutionsQ4 2022: 91 institutionsQ1 2023: 81 institutionsQ2 2023: 87 institutionsQ3 2023: 82 institutionsQ4 2023: 79 institutionsQ1 2024: 84 institutionsQ2 2024: 80 institutionsQ3 2024: 65 institutionsQ4 2024: 67 institutionsQ1 2025: 43 institutionsQ2 2025: 39 institutionsQ3 2025: 43 institutionsQ4 2025: 41 institutionsQ1 2026: 36 institutionsQ2 2026: 21 institutions
Value heldQ2 2024: $30.4M
Q1 2021: $964.6MQ2 2021: $897.0MQ3 2021: $746.4MQ4 2021: $518.4MQ1 2022: $127.7MQ2 2022: $67.1MQ3 2022: $191.5MQ4 2022: $279.2MQ1 2023: $87.6MQ2 2023: $96.1MQ3 2023: $51.3MQ4 2023: $66.6MQ1 2024: $87.2MQ2 2024: $30.4MQ3 2024: $31.0MQ4 2024: $14.2MQ1 2025: $4.77MQ2 2025: $5.21MQ3 2025: $9.19MQ4 2025: $7.49MQ1 2026: $2.52MQ2 2026: $1.22M
Institutions holding BCAB and their total value by quarter
QuarterHoldersValue
Q2 202621$1.22M
Q1 202636$2.52M
Q4 202541$7.49M
Q3 202543$9.19M
Q2 202539$5.21M
Q1 202543$4.77M
Q4 202467$14.2M
Q3 202465$31.0M
Q2 202480$30.4M
Q1 202484$87.2M
Q4 202379$66.6M
Q3 202382$51.3M
Q2 202387$96.1M
Q1 202381$87.6M
Q4 202291$279.2M
Q3 202273$191.5M
Q2 202280$67.1M
Q1 202297$127.7M
Q4 202181$518.4M
Q3 202187$746.4M
Q2 202176$897.0M
Q1 202162$964.6M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding BioAtla, Inc.; share changes are against Q1 2024.

Institutions holding BCAB in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Price T Rowe Associates Inc0$00.00%−12,791−100.0%Sold out
SG Americas Securities, LLC0$00.00%−13,069−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−12,400−100.0%Sold out
Belvedere Trading LLC0$00.00%−11,734−100.0%Sold out
California State Teachers Retirement System0$00.00%−4,447−100.0%Sold out
Legal & General Group Plc0$00.00%−4,239−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−3,653−100.0%Sold out
Amalgamated Bank0$00.00%−1,491−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−477−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−8−100.0%Sold out